Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD70 antibody-drug conjugates and their use for the treatment and prevention of cancer and immune disorders

Anti-CD70 antibody-drug conjugates and their use for the treatment and prevention of cancer and immune disorders

US Patent 8663642 · Granted Mar 4, 2014

Estimated economic value: $49,572,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic vaccine for hepatitis b virus (HBV) using the HBV core antigen2025
Synergistic effects between auristatin-based antibody drug conjugates and inhibi2025
Synergistic effects between auristatin-based antibody drug conjugates and inhibi2025
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV PreS1 and/or PreS22025
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV core antigen2024
Synergistic effects between auristatin-based antibody drug conjugates and inhibi2023
Synergistic effects between auristatin-based antibody drug conjugates and inhibi2023
Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV PreS1 and/or PreS22022
Anti-NTB-A antibodies and related compositions and methods2022
Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV core antigen2022
Dosage and administration of non-fucosylated anti-CD40 antibodies2022
Dosage and administration of non-fucosylated anti-CD40 antibodies2021